Covered recipient · General Payments record
JAMES S PARSONS
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2018–2024
$11,299.22
- Reported across 338 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $385.35 | 27 |
| Education | $64.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $163.96 | 13 |
| Novo Nordisk AS | $162.97 | 11 |
| Astellas Pharma US Inc | $64.99 | 1 |
| Exact Sciences Corporation | $33.05 | 2 |
| Acerta Pharma LLC | $25.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.07 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187606 | CMS |
| ABBVIE INC. | $6.04 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187608 | CMS |
| ABBVIE INC. | $9.81 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187610 | CMS |
| ABBVIE INC. | $5.93 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187612 | CMS |
| ABBVIE INC. | $11.90 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187614 | CMS |
| ABBVIE INC. | $13.53 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187616 | CMS |
| ABBVIE INC. | $24.09 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187618 | CMS |
| ABBVIE INC. | $17.36 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187620 | CMS |
| ABBVIE INC. | $2.67 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187622 | CMS |
| ABBVIE INC. | $20.81 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187624 | CMS |
| ABBVIE INC. | $4.60 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187626 | CMS |
| ABBVIE INC. | $16.16 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187628 | CMS |
| ABBVIE INC. | $14.99 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187630 | CMS |
| Astellas Pharma US Inc | $64.99 | 01/15/2024 | Education | Undisputed | 01/23/2026 | 1139388360 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.37 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105347428 | CMS |
| Exact Sciences Corporation | $17.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114823877 | CMS |
| Exact Sciences Corporation | $15.44 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114823882 | CMS |
| Novo Nordisk Inc | $11.37 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934399 | CMS |
| Novo Nordisk Inc | $16.13 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096897296 | CMS |
| Novo Nordisk Inc | $19.46 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097807121 | CMS |
| Novo Nordisk Inc | $20.66 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619858 | CMS |
| Novo Nordisk Inc | $19.97 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097409443 | CMS |
| Novo Nordisk Inc | $10.04 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096940363 | CMS |
| Novo Nordisk Inc | $21.17 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096868245 | CMS |
| Novo Nordisk Inc | $6.56 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097814290 | CMS |
| Novo Nordisk Inc | $9.42 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097124008 | CMS |
| Novo Nordisk Inc | $17.62 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097295961 | CMS |
| Novo Nordisk Inc | $10.57 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097452676 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.